Cytodyn Inc (CYDY)

[stockorus]

Unless Cytodyn did not really include NEWS2 as a secondary endpoint for CD10.

"The National Early Warning Score (NEWS) is an objective scale developed by the Royal College of Physicians to identify patients at risk for rapid clinical deterioration requiring critical care intervention. NEWS2 (the latest version), is being used as an endpoint in several other COVID-19 clinical trials, including CytoDyn's severe-to-critical COVID-19 Phase 3 trial."

(https://www.cytodyn.com/newsroom/press-releases/detail/458/cytodyn-announces-clinically-significant-top-line-results)

Reading this, one wonders whether they are saying that for many other trials, NEWS2 is used as endpoint. And after noticing it succeeded in CD10, decided to informally tell us it was a (typical) secondary that was SS for us.

Otherwise I can't explain how FDA would make such a crucial error.